Filter By Industry
Filter By Tag

Newsroom

InvisiDerm Healthcare Press releases

1 - 1 of 1 Press Release

InvisiDerm Announces Zero Adverse Effects
Jun 10, 2014
InvisiDerm Announces Zero Adverse Effects Two Years After Successful D`OXYVA® Landmark Human Clinical Study - New Randomized Human Clinical Study at Penn State University


InvisiDerm Healthcare RSS Feed